Clinical trial
EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab…
NCT00001563 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001563 |
|---|---|
| Title | EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma |
| Official title | EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AIDS Related Lymphoma, AIDS-Associated Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | Filgrastim, Rituximab, EPOCH |
| Enrollment | 39 |
| Start date | Jan 8, 1997 |
| Primary completion | May 5, 2005 |
| Completion | May 5, 2005 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 19, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: